Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANVS | AZN | AMGN | GILD | VRTX |
| Company | Annovis Bio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.8800 | 187.07 | 362.63 | 127.28 | 502.71 |
| High | 1.9600 | 187.65 | 364.00 | 127.62 | 502.71 |
| Low | 1.8672 | 183.49 | 357.89 | 125.13 | 494.80 |
| Latest | 1.9200 | 183.86 | 361.33 | 125.97 | 498.01 |
| Change | +0.0600 | -5.76 | -0.79 | -0.37 | +1.28 |
| % Change | +3.23% | -3.04% | -0.22% | -0.29% | +0.26% |
| Volume | 716,300 | 2,115,400 | 2,244,700 | 6,654,900 | 1,444,500 |
| 20-Day Average Volume | 982,150 | 2,030,095 | 3,230,705 | 9,403,995 | 1,873,385 |
| Previous Close | 1.8600 | 189.62 | 362.12 | 126.34 | 496.73 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7950 | 181.84 | 349.33 | 126.00 | 461.09 |
| 20-Day Raw Stochastic | 65.48% | 58.40% | 92.98% | 44.60% | 92.99% |
| 20-Day Relative Strength | 50.94 | 49.50 | 59.94 | 45.28 | 68.62 |
| Weighted Alpha | -35.66 | +23.41 | +21.41 | +7.39 | +16.23 |
| Today's Opinion | 88% Sell | 24% Sell | 56% Buy | 88% Sell | 72% Buy |
| Previous Opinion | 88% Sell | 8% Buy | 56% Buy | 56% Sell | 72% Buy |
| Last Month's Opinion | 80% Sell | 40% Sell | 40% Sell | 24% Sell | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.94% since 06/24/26 | +0.46% since 06/24/26 | +2.82% since 06/24/26 | +0.65% since 06/24/26 | +4.80% since 06/24/26 |
| Low | 1.6450 on 06/25/26 | 183.49 on 07/01/26 | 350.06 on 06/25/26 | 123.67 on 06/25/26 | 473.50 on 06/25/26 |
| High | 1.9600 on 07/01/26 | 191.13 on 06/29/26 | 364.00 on 07/01/26 | 128.86 on 06/29/26 | 503.89 on 06/26/26 |
| 1-Month | |||||
| %Chg | +5.49% since 06/01/26 | +2.31% since 06/01/26 | +9.78% since 06/01/26 | -3.91% since 06/01/26 | +13.60% since 06/01/26 |
| Low | 1.6450 on 06/25/26 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 2.0650 on 06/04/26 | 191.13 on 06/29/26 | 364.00 on 07/01/26 | 131.66 on 06/05/26 | 503.89 on 06/26/26 |
| 3-Month | |||||
| %Chg | -9.43% since 04/01/26 | -8.40% since 04/01/26 | +2.28% since 04/01/26 | -10.21% since 04/01/26 | +11.35% since 04/01/26 |
| Low | 1.5407 on 04/10/26 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 2.7700 on 04/06/26 | 207.30 on 04/10/26 | 364.00 on 07/01/26 | 142.97 on 04/09/26 | 503.89 on 06/26/26 |
| 6-Month | |||||
| %Chg | -44.51% since 12/31/25 | unch since 12/31/25 | +10.39% since 12/31/25 | +2.63% since 12/31/25 | +9.85% since 12/31/25 |
| Low | 1.5407 on 04/10/26 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 4.1400 on 01/08/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 66,522 | 285,149,952 | 195,012,672 | 156,400,576 | 126,397,432 |
| Shares Outstanding, K | 34,647 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -28,850,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -17,610,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 1.19 | 0.24 | 0.41 | 0.32 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.63 on 05/15/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/11/26 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.48 | 16.39 | 15.09 | 29.53 |